SCHEMBL18319002

SCHEMBL18319002

COc1ccc2ncc(-c3ccc(OC4CCN(C(=O)OC(C)(C)C)CC4)cc3)cc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.56
GPR119 Q8TDV5 7/20 0.49
HTT P42858 2/20 0.48
PIK3CD O00329 2/20 0.47
PIK3CA P42336 2/20 0.47
PIK3CB P42338 2/20 0.47
PIK3CG P48736 2/20 0.47
PDGFRB P09619 1/20 0.47
PDGFRA P16234 1/20 0.47
ALDH1A1 P00352 2/20 0.46
DYRK1A Q13627 1/20 0.46
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
CRHBP P24387 1/20 0.45
KMT2A Q03164 1/20 0.45
CRHR2 Q13324 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18318309 0.93 CHEK2 (0.54) CHEK2GPR119HTTPDGFRBPDGFRA
SCHEMBL18319178 0.91 CHEK2 (0.56) CHEK2GPR119PDE3BPDE3A
SCHEMBL18318434 0.87 CHEK2 (0.51) CHEK2GPR119HTTPIK3CDPIK3CA
SCHEMBL18318788 0.87 CHEK2 (0.50) CHEK2GPR119HTTPIK3CDPIK3CA
SCHEMBL18318601 0.87 CHEK2 (0.50) CHEK2GPR119HTTPIK3CDPIK3CA
SCHEMBL18318241 0.86 PDGFRB (0.50) CHEK2PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL18319494 0.85 CHEK2 (0.54) CHEK2GPR119
SCHEMBL18319021 0.85 PIK3CA (0.51) PIK3CDPIK3CAPIK3CBPIK3CGPDGFRB
SCHEMBL18318188 0.83 PIK3CD (0.53) CHEK2GPR119HTTPIK3CDPIK3CA
SCHEMBL18318580 0.81 CHEK2 (0.51) CHEK2GPR119HTTPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257035-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2025-08-14 US disclosed
US-12098130-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2024-09-24 US disclosed
US-20230391723-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2023-12-07 US disclosed
US-11702388-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2023-07-18 US disclosed
US-20210230116-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2021-07-29 US disclosed
CN-107847765-B 1, 4-substituted piperidine derivatives 89生物有限公司 2021-05-04 CN disclosed
US-10851057-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2020-12-01 US disclosed
EP-3310441-B1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES 89BIO LTD (IL) 2020-07-29 EP disclosed
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2019-05-23 US disclosed
US-10221135-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2019-03-05 US disclosed
US-20180179159-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2018-06-28 US disclosed
EP-3310441-A1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES Cephalon, Inc. (US) 2018-04-25 EP disclosed
US-9902696-B2 1,4-substituted piperidine derivatives CEPHALON, INC. (US) 2018-02-27 US disclosed
WO-2016205633-A1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON, INC. (US) 2016-12-22 WO disclosed
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257035-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A CHEK2 4678/4885GPR119 223/4885HTT 3733/4885
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A CHEK2 4678/4885GPR119 223/4885HTT 3733/4885
US-20230391723-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A CHEK2 4678/4885GPR119 223/4885HTT 3733/4885
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A CHEK2 4678/4885GPR119 223/4885HTT 3733/4885
US-20210230116-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A CHEK2 4678/4885GPR119 223/4885HTT 3733/4885
US-10221135-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A CHEK2 4678/4885GPR119 223/4885HTT 3733/4885
US-11702388-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A CHEK2 4678/4885GPR119 223/4885HTT 3733/4885
US-12098130-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A CHEK2 4678/4885GPR119 223/4885HTT 3733/4885
US-10851057-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A CHEK2 4678/4885GPR119 223/4885HTT 3733/4885
US-20180179159-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A CHEK2 4673/4885GPR119 225/4885HTT 3682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.